ETCHX
Price
$27.11
Change
+$0.33 (+1.23%)
Updated
May 8 closing price
Net Assets
1.03B
FSPHX
Price
$25.23
Change
-$0.05 (-0.20%)
Updated
May 8 closing price
Net Assets
6.2B
Ad is loading...

ETCHX vs FSPHX

Header iconETCHX vs FSPHX Comparison
Open Charts ETCHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences C
Price$27.11
Change+$0.33 (+1.23%)
VolumeN/A
Net Assets1.03B
Fidelity Select Health Care
Price$25.23
Change-$0.05 (-0.20%)
VolumeN/A
Net Assets6.2B
ETCHX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETCHX vs. FSPHX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETCHX is a Buy and FSPHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.2B vs. ETCHX (1.03B). FSPHX pays higher dividends than ETCHX: FSPHX (0.02) vs ETCHX (0.00). ETCHX was incepted earlier than FSPHX: ETCHX (12 years) vs FSPHX (44 years). ETCHX (2.32) is less costly to investors than FSPHX (0.63). ETCHX is a more actively managed with annual turnover of: 71.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than ETCHX: FSPHX (0) vs ETCHX (1000). FSPHX annual gain was more profitable for investors over the last year : -11.31 vs. ETCHX (-14.74). FSPHX return over 5 years is better than : -11.47 vs. ETCHX (-24.98).
ETCHXFSPHXETCHX / FSPHX
Total Expense Ratio2.320.63368%
Annual Report Gross Expense Ratio2.320.63368%
Fund Existence12 years44 years-
Gain YTD-8.413-7.229116%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B6.2B17%
Annual Yield % from dividends0.000.02-
Returns for 1 year-14.74-11.31130%
Returns for 3 years25.085.18485%
Returns for 5 years-24.98-11.47218%
Returns for 10 years13.458.19164%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX24.910.38
+1.55%
Beck Mack + Oliver Partners
WBENX12.40N/A
N/A
William Blair Emerging Mkts Growth N
IJSIX14.82N/A
N/A
VY® JPMorgan Small Cap Core Equity I
VMACX56.24N/A
N/A
Virtus KAR Mid-Cap Core A
AULYX91.91N/A
N/A
American Century Ultra® Y